Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population

被引:156
作者
Brink, PA
Crotti, L
Corfield, V
Goosen, A
Durrheim, G
Hedley, P
Heradien, M
Geldenhuys, G
Vanoli, E
Bacchini, S
Spazzolini, C
Lundquist, AL
Roden, DM
George, AL
Schwartz, PJ
机构
[1] IRCCS, Policlin San Matteo, Dept Cardiol, I-27100 Pavia, Italy
[2] Univ Stellenbosch, Dept Internal Med, ZA-7600 Stellenbosch, South Africa
[3] Univ Stellenbosch, US MRC, Ctr Cellular & Mol Biol, ZA-7600 Stellenbosch, South Africa
[4] Univ Stellenbosch, Bur Ind Math, ZA-7600 Stellenbosch, South Africa
[5] Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy
[6] IRCCS, Policlin San Matteo, Pavia, Italy
[7] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
[8] Vanderbilt Univ, Dept Med, Nashville, TN USA
关键词
arrhythmia; death; sudden; genetics; long-QT syndrome; nervous system; autonomic;
D O I
10.1161/CIRCULATIONAHA.105.572453
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-In the congenital long-QT syndrome (LQTS), there can be a marked phenotypic heterogeneity. Founder effects, by which many individuals share a mutation identical by descent, represent a powerful tool to further understand the underlying mechanisms and to predict the natural history of mutation-associated effects. We are investigating one such founder effect, originating in South Africa in approximately AD 1700 and segregating the same KCNQ1 mutation ( A341V). Methods and Results-The study population involved 320 subjects, 166 mutation carriers (MCs) and 154 noncarriers. When not taking beta-blocker therapy, MCs had a wide range of QTc values ( 406 to 676 ms), and 12% of individuals had a normal QTc ( <= 440 ms). A QTc > 500 ms was associated with increased risk for cardiac events ( OR = 4.22; 95% CI, 1.12 to 15.80; P = 0.033). We also found that MCs with a heart rate < 73 bpm were at significantly lower risk ( OR = 0.23; 95% CI, 0.06 to 0.86; P = 0.035). This study also unexpectedly determined that KCNQ1-A341V is associated with greater risk than that reported for large databases of LQT1 patients: A341V MCs are more symptomatic by age 40 years (79% versus 30%) and become symptomatic earlier ( 7 +/- 4 versus 13 +/- 9 years, both P < 0.001). Accordingly, functional studies of KCNQ1-A341V in CHO cells stably expressing IKs were conducted and identified a dominant negative effect of the mutation on wild-type channels. Conclusions-KCNQ1-A341V is a mutation associated with an unusually severe phenotype, most likely caused by the dominant negative effect of the mutation. The availability of an extended kindred with a common mutation allowed us to identify heart rate, an autonomic marker, as a novel risk factor.
引用
收藏
页码:2602 / 2610
页数:9
相关论文
共 40 条
[21]   Coassembly of K(v)LQT1 and minK (IsK) proteins to form cardiac I-Ks potassium channel [J].
Sanguinetti, MC ;
Curran, ME ;
Zou, A ;
Shen, J ;
Spector, PS ;
Atkinson, DL ;
Keating, MT .
NATURE, 1996, 384 (6604) :80-83
[22]  
Schwartz P., 2004, CARDIAC ELECTROPHYSI, P651, DOI [10.1016/b0-7216-0323-8/50073-7, DOI 10.1016/B0-7216-0323-8/50073-7]
[23]  
SCHWARTZ P J, 1989, Journal of the American College of Cardiology, V13, p20A
[24]   LONG QT SYNDROME PATIENTS WITH MUTATIONS OF THE SCN5A AND HERG GENES HAVE DIFFERENTIAL RESPONSES TO NA+ CHANNEL BLOCKADE AND TO INCREASES IN HEART-RATE - IMPLICATIONS FOR GENE-SPECIFIC THERAPY [J].
SCHWARTZ, PJ ;
PRIORI, SG ;
LOCATI, EH ;
NAPOLITANO, C ;
CANTU, F ;
TOWBIN, JA ;
KEATING, MT ;
HAMMOUDE, H ;
BROWN, AM ;
CHEN, LSK ;
COLATSKY, TJ .
CIRCULATION, 1995, 92 (12) :3381-3386
[25]  
Schwartz PJ, 2001, CIRCULATION, V103, P89
[26]   Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome [J].
Schwartz, PJ ;
Priori, SG ;
Cerrone, M ;
Spazzolini, C ;
Odero, A ;
Napolitano, C ;
Bloise, R ;
De Ferrari, GM ;
Klersy, C ;
Moss, AJ ;
Zareba, W ;
Robinson, JL ;
Hall, WJ ;
Brink, PA ;
Toivonen, L ;
Epstein, AE ;
Li, CL ;
Hu, DY .
CIRCULATION, 2004, 109 (15) :1826-1833
[27]   ELECTRICAL ALTERNATION OF T-WAVE - CLINICAL AND EXPERIMENTAL EVIDENCE OF ITS RELATIONSHIP WITH SYMPATHETIC NERVOUS-SYSTEM AND WITH LONG Q-T SYNDROME [J].
SCHWARTZ, PJ ;
MALLIANI, A .
AMERICAN HEART JOURNAL, 1975, 89 (01) :45-50
[28]  
Schwartz PJ., 1980, SUDDEN DEATH, P358
[29]   Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels [J].
Seebohm, G ;
Pusch, M ;
Chen, J ;
Sanguinetti, MC .
CIRCULATION RESEARCH, 2003, 93 (10) :941-947
[30]   Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome - Multicenter study in Japan [J].
Shimizu, W ;
Horie, M ;
Ohno, S ;
Takenaka, K ;
Yamaguchi, M ;
Shimizu, M ;
Washizuka, T ;
Aizawa, Y ;
Nakamura, K ;
Ohe, T ;
Aiba, T ;
Miyamoto, Y ;
Yoshimasa, Y ;
Towbin, JA ;
Priori, SG ;
Kamakura, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (01) :117-125